FMC

EX-99.1

2 fmcex991093026.htm

EX-99.1

Document

Exhibit 99.1

FMC Corporation

2929 Walnut Street

Philadelphia, PA 19104

USA

News Release215.299.6000

fmc.com

For Release: Immediate

Media contact: Nicole Canning +1.215.299.5916

Nicole.Canning@fmc.com

Investor Contact: Curt Brooks +1.215.299.6137

Curt.Brooks@fmc.com

FMC Corporation Reports Third-Quarter 2026 Results and Revised Fourth-Quarter Outlook

Company provides additional detail on financial impact of previously announced commercial actions

Third Quarter 2026 Highlights

•Revenue of $106 million, down $436 million versus Q3 2025, including an approximately $639 million negative impact from previously announced commercial actions

•Consolidated GAAP net loss of $2.07 billion, a decline of $1.50 billion versus Q3 2025 driven by non-cash adjustments recorded in connection with deferred tax assets and intangible assets, as well as the commercial actions

•Adjusted EBITDA of negative $559 million, down $795 million versus Q3 2025, including an approximately $672 million negative impact from the commercial actions

•Consolidated GAAP net loss of $15.54 per diluted share, down $11.02 versus Q3 2025

•Adjusted loss per diluted share of $4.41, down $5.30 versus Q3 2025

•GAAP cash from operations of $7 million, an increase of $191 million versus Q3 2025

•Free cash flow of negative $18 million, an improvement of $214 million versus Q3 2025

Outlook1

•Fourth quarter revenue excluding India lowered to a range of $1.04 billion to $1.14 billion, essentially flat at the midpoint versus 2025

•Fourth quarter Adjusted EBITDA lowered to a range of $210 million to $230 million, a decline of 22 percent at the midpoint

•Fourth quarter Adjusted earnings per diluted share lowered to a range of $0.56 to $0.70, a decline of 48 percent at the midpoint

•Full year free cash flow now expected to be negative $350 million to negative $150 million

PHILADELPHIA, October 29, 2026 –FMC Corporation (NYSE:FMC) today reported third quarter 2026 revenue of $106 million, compared with $542 million in the prior-year period. Third-quarter sales include a $639 million negative impact from the commercial actions announced on October 15, 2026, to modify the company’s pricing and rebate model in North America and to address select higher-priced products held by channel customers in key markets.

1

Page 2 /FMC Corporation Reports Third-Quarter 2026 Results and Revised Fourth-Quarter Outlook

“We are taking significant action to address elevated inventory values in the channel and improve the movement of FMC products to growers," said Pierre Brondeau, chairman, chief executive officer and president. "Our third-quarter results reflected both the substantial impact of these actions and weaker than expected demand. Our priority now is disciplined execution with our customers. We believe completing this work, together with the progress across our operational priorities, positions FMC for improved performance in 2027 and a stronger growth and earnings profile in 2028."

FMC RevenueQ3 2026

Total Revenue Change (GAAP)(80)%

Less: Revenue for India held for sale business9%

Total Revenue Change (ex-India) (Non-GAAP)(89)%

Less Commercial Actions67%

Like-for-Like Revenue Change (Before-Commercial Actions) (Non-GAAP)(22)%

Totals may not sum due to rounding

Third-quarter revenue, excluding India and the commercial actions, was $745 million, a decline of 22 percent versus the prior-year period which excluded India. Volume declined 21 percent due to challenging market conditions with channel customers in several key markets sharply reducing replenishment orders during the final weeks of the quarter. Price declined 2 percent. Foreign currency was a 1 percent tailwind.

FMC Regional Revenue ($M)Q3 2026Q3 2025

North America(371)244

Latin America264463

EMEA121155

Asia (excluding 2026 India)1 9199

2026 India1 0(419)

Total Revenue (GAAP)106542

Totals may not sum due to rounding

2

Page 3 /FMC Corporation Reports Third-Quarter 2026 Results and Revised Fourth-Quarter Outlook

GAAP net loss was $2.07 billion, compared with a net loss of $569 million in the prior-year period, primarily due to non-cash adjustments recorded in connection with deferred tax assets and intangible assets, as well as the commercial actions taken in the third quarter. Third-quarter Adjusted EBITDA was negative $559 million, compared with $236 million in the prior-year period. Excluding the approximately $672 million negative impact of the commercial actions, underlying Adjusted EBITDA was $113 million. This result was lower than the prior year with lower sales and an FX headwind partially offset by favorable costs.

On a GAAP basis, cash from operations was $7 million, compared to negative $184 million in the prior-year period. Free cash flow was negative $18 million including $23 million for restructuring spend. The free cash flow improvement of $214 million versus third quarter 2025 is mainly due to favorable wor

EX-99.1

2 ex99110152026.htm

EX-99.1

Document

Exhibit 99.1

FMC Corporation

2929 Walnut Street

Philadelphia, PA 19104

USA

News Release215.299.6000

fmc.com

For Release: Immediate

Media contact: Nicole Canning +1.215.299.5916

Nicole.Canning@fmc.com

Investor Contact: Curt Brooks +1.215.299.6137

Curt.Brooks@fmc.com

FMC Corporation Provides Update to Third-Quarter Expectations and Announces Comprehensive Commercial Actions to Expedite Return to Growth

•Third-quarter revenue1 is now expected to be $65 million to $125 million, with Adjusted EBITDA2 expected to be negative $565 million to negative $510 million

•Revised expectations now include commercial actions which are resulting in approximately $625 million to $675 million in charges impacting revenue1 and Adjusted EBITDA2

•Commercial actions are expected to accelerate movement of FMC products through the channel, supporting future replenishment demand

PHILADELPHIA, October 15, 2026 – FMC Corporation (NYSE:FMC) today updated its expectations for third quarter 2026. Revenue1 is now expected to be between $65 million and $125 million with expected Adjusted EBITDA2 of negative $565 million to negative $510 million. These estimates include an estimated $625 million to $675 million impact related to commercial actions to lower the price of select products held by channel customers in key markets and to modify the selling and pricing model in the United States.

“Third-quarter demand was weaker than we expected, driven by challenging market conditions and elevated levels of higher-priced FMC products held in inventory by certain channel customers, which are limiting product movement and replenishment demand,” said Pierre Brondeau, chairman, chief executive officer and president. “We have addressed this issue incrementally over several quarters, but under current market conditions, we determined that more comprehensive actions are necessary.”

Page 2/ FMC Corporation Provides Update to Third-Quarter Expectations and Announces Comprehensive Commercial Actions to Expedite Return to Growth

Overview of Commercial Actions

The critical commercial issue facing FMC is slower-than-expected demand from channel customers in key markets. Under current market conditions, distributors are seeking to operate with the lowest inventory levels FMC has experienced. Although the company made meaningful progress reducing channel inventory volumes in 2025, certain higher-priced FMC products are increasing the overall value of FMC inventory held by some customers. These products entered the channel under different cost structures, intellectual property positions and competitive conditions. Rapid market price declines, driven in part by increased generic competition, have widened the gap between the value of affected inventory and current market prices, limiting movement of those products to growers.

The company views its current pricing as competitive and expects ongoing manufacturing changes to further support competitive pricing. To accelerate product movement and support replenishment demand, FMC is taking two significant actions.

First, the company is taking comprehensive commercial actions in Brazil, Argentina, the United States and Canada to lower the price of select products held by channel customers.

Second, FMC will modify its selling and pricing model in the United States. Historically, products have been sold using a high gross-price and high-rebate structure. FMC intends to significantly reduce the gap between gross and net pricing, simplifying customer economics, improving channel health and better aligning pricing with current market realities.

Together, these two actions are expected to remove a considerable constraint on the movement of FMC products through the channel to growers and to support future replenishment demand from channel customers.

"The actions we have taken under our 2026 operational priorities, combined with these critical commercial actions, are expected to significantly improve the company's overall competitiveness," said Brondeau. "We believe removing this hurdle is an important step in completing the company's transformation and positioning FMC to operate at its full potential in 2027, 2028 and the long term."

Information in this news release is preliminary and intended to provide an update to third-quarter expectations. The company will provide more information regarding its quarter results and its 2026 financial outlook when it reports third-quarter earnings on October 29, 2026. In addition, the company will share its preliminary expectations for 2027 and 2028 on its earnings call on October 30, 2026.

Page 3/ FMC Corporation Provides Update to Third-Quarter Expectations and Announces Comprehensive Commercial Actions to Expedite Return to Growth

While the company expects to be in compliance with covenants at September 30, 2026, the company intends to engage in discussions with its bank group on potential further modification

EX-99.1

2 fmcex991063026.htm

EX-99.1

Document

Exhibit 99.1

FMC Corporation

2929 Walnut Street

Philadelphia, PA 19104

USA

News Release215.299.6000

fmc.com

For Release: Immediate

Media contact: Nicole Canning +1.215.299.5916

Nicole.Canning@fmc.com

Investor Contact: Curt Brooks +1.215.299.6137

Curt.Brooks@fmc.com

FMC Corporation reports second quarter 2026 results with Adjusted EBITDA above high end of guidance range and solid cash generation

Updates full-year outlook to reflect more challenging macro environment; Company continues to focus on execution of operational priorities

Second Quarter 2026 Highlights

•Revenue of $867 million, down 17 percent versus Q2 2025

◦Revenue excluding India1 of $841 million, down 20 percent versus Q2 2025 (which included India)

◦Organic revenue2 for the period declined 22 percent

•Consolidated GAAP net loss of $187 million, a decline of $253 million versus Q2 2025

•Adjusted EBITDA of $153 million, down 26 percent versus Q2 2025

•Consolidated GAAP net loss of $1.49 per diluted share, down $2.02 versus Q2 2025

•Adjusted earnings per diluted share of $0.26, down 62% versus Q2 2025

•GAAP cash from operations of $363 million, an increase of $297 million versus Q2 2025

Full-Year Outlook1

•Revenue excluding India lowered to a range of $3.50 billion to $3.70 billion, a decline of 7 percent at the midpoint versus 2025

◦Excluding 2025 India contributions, the 2026 outlook represents a decline at the midpoint of 5 percent

•Adjusted EBITDA lowered to a range of $620 million to $680 million, a decline of 23 percent at the midpoint

•Adjusted earnings per diluted share lowered to a range of $1.19 to $1.49, a decline of 55 percent at the midpoint

•Free cash flow, which now includes the upfront licensing payment for rimisoxafen of $200 million, increased to a range of $75 million to $225 million

1

Page 2 / FMC Corporation reports second quarter 2026 results including with Adjusted EBITDA above high end of guidance range and solid cash generation

PHILADELPHIA, July 29, 2026 – FMC Corporation (NYSE:FMC) today reported second quarter 2026 revenue of $867 million, down 17 percent versus second quarter 2025. Second quarter 2026 revenue, excluding India, was $841 million, down 20 percent versus second quarter 2025, which included India. On a GAAP basis, the company reported a loss of $1.49 per diluted share in the second quarter, a decrease of $2.02 versus second quarter 2025. Second quarter adjusted earnings per diluted share of $0.26 was down 62 percent versus second quarter 2025.

"During the quarter, we completed several important actions that strengthened FMC's financial foundation and provide greater flexibility to execute our strategy," said Pierre Brondeau, chairman, chief executive officer and president. "With the strategic review now concluded, we have clarity on the path forward and remain focused on improving competitiveness, advancing our technology portfolio and positioning the company for long-term growth."

FMC RevenueQ2 2026

Total Revenue Change (GAAP)(17)%

Total Revenue Change (ex-India) (Non-GAAP)(20)%

Less: 2025 revenue for India held for sale business(5)%

Like-for-Like Revenue Change (Non-GAAP)(15)%

Second quarter sales of $841 million, excluding India, were 20 percent lower than prior year. The removal of India represented a 5 percent sales headwind. Volumes declined 10 percent due to lower diamide partner orders and reduced demand for core legacy products, particularly in North America, as growers contend with strained margins. Price declined 7 percent, driven by pressure on the company's core legacy products and planned Rynaxypyr® active pricing actions. Foreign currency was a 2 percent tailwind. The growth portfolio grew mid-single digits as lower Plant Health sales were more than offset by strong performances from new active ingredients and Cyazypyr® active, reflecting continued demand for innovative solutions. Branded sales of Rynaxypyr® were essentially flat versus prior year, excluding India, with strong demand for new formulations.

2

Page 3 / FMC Corporation reports second quarter 2026 results including with Adjusted EBITDA above high end of guidance range and solid cash generation

FMC Regional Revenue ($M)Q2 2026Q2 2025

North America$249$321

Latin America$278$310

EMEA$214$260

Asia (excluding 2026 India)1 $101$159

2026 India1 $26-

Total Revenue (GAAP)$867$1,051

Totals may not sum due to rounding

GAAP net loss in the second quarter declined $253 million primarily due to lower sales, higher restructuring costs and higher interest expense. FMC second quarter Adjusted EBITDA was $153 million, a decrease of 26 percent from the prior-year period. Lower price and volume were partially offset by favorable costs and a moderate FX tailwind.

On a GAAP basis, cash from operations for the second quarter was $363 million, an increase of $297 million versus 2025, including a $200 million upfront payment related to the rimisoxafe